These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 34225946)

  • 1. The subthalamic nucleus and the placebo effect in Parkinson's disease.
    Frisaldi E; Zamfira DA; Benedetti F
    Handb Clin Neurol; 2021; 180():433-444. PubMed ID: 34225946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of the thalamic-subthalamic circuit involved in the placebo response through single-neuron recording in Parkinson patients.
    Frisaldi E; Carlino E; Lanotte M; Lopiano L; Benedetti F
    Cortex; 2014 Nov; 60():3-9. PubMed ID: 24457096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuronal inhibition and synaptic plasticity of basal ganglia neurons in Parkinson's disease.
    Milosevic L; Kalia SK; Hodaie M; Lozano AM; Fasano A; Popovic MR; Hutchison WD
    Brain; 2018 Jan; 141(1):177-190. PubMed ID: 29236966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Motor and cognitive placebo-/nocebo-responses in Parkinson's disease patients with deep brain stimulation.
    Keitel A; Wojtecki L; Hirschmann J; Hartmann CJ; Ferrea S; Südmeyer M; Schnitzler A
    Behav Brain Res; 2013 Aug; 250():199-205. PubMed ID: 23651878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors influencing the outcome of deep brain stimulation: Placebo, nocebo, lessebo, and lesion effects.
    Mestre TA; Lang AE; Okun MS
    Mov Disord; 2016 Mar; 31(3):290-6. PubMed ID: 26952118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional segregation of basal ganglia pathways in Parkinson's disease.
    Neumann WJ; Schroll H; de Almeida Marcelino AL; Horn A; Ewert S; Irmen F; Krause P; Schneider GH; Hamker F; Kühn AA
    Brain; 2018 Sep; 141(9):2655-2669. PubMed ID: 30084974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simultaneous low-frequency deep brain stimulation of the substantia nigra pars reticulata and high-frequency stimulation of the subthalamic nucleus to treat levodopa unresponsive freezing of gait in Parkinson's disease: A pilot study.
    Valldeoriola F; Muñoz E; Rumià J; Roldán P; Cámara A; Compta Y; Martí MJ; Tolosa E
    Parkinsonism Relat Disord; 2019 Mar; 60():153-157. PubMed ID: 30241951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional imaging of subthalamic nucleus deep brain stimulation in Parkinson's disease.
    Boertien T; Zrinzo L; Kahan J; Jahanshahi M; Hariz M; Mancini L; Limousin P; Foltynie T
    Mov Disord; 2011 Aug; 26(10):1835-43. PubMed ID: 21674623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deep brain stimulation of the substantia nigra for freezing of gait in Parkinson's disease: is it about stimulation frequency?
    Weiss D; Milosevic L; Gharabaghi A
    Parkinsonism Relat Disord; 2019 Jun; 63():229-230. PubMed ID: 30579819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced visual responses in the superior colliculus and subthalamic nucleus in an animal model of Parkinson's disease.
    Rolland M; Carcenac C; Overton PG; Savasta M; Coizet V
    Neuroscience; 2013 Nov; 252():277-88. PubMed ID: 23916713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of inhibitory plasticity in basal ganglia output nuclei of patients with Parkinson's disease.
    Milosevic L; Gramer R; Kim TH; Algarni M; Fasano A; Kalia SK; Hodaie M; Lozano AM; Popovic MR; Hutchison WD
    Neurobiol Dis; 2019 Apr; 124():46-56. PubMed ID: 30391540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reversible improvement in severe freezing of gait from Parkinson's disease with unilateral interleaved subthalamic brain stimulation.
    Brosius SN; Gonzalez CL; Shuresh J; Walker HC
    Parkinsonism Relat Disord; 2015 Dec; 21(12):1469-70. PubMed ID: 26482492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tractography patterns of subthalamic nucleus deep brain stimulation.
    Vanegas-Arroyave N; Lauro PM; Huang L; Hallett M; Horovitz SG; Zaghloul KA; Lungu C
    Brain; 2016 Apr; 139(Pt 4):1200-10. PubMed ID: 26921616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simultaneous low-frequency deep brain stimulation of the substantia nigra pars reticulata and high-frequency stimulation of the subthalamic nucleus to treat levodopa unresponsive freezing of gait in Parkinson's disease: A pilot study.
    Valldeoriola F
    Parkinsonism Relat Disord; 2019 Jun; 63():231. PubMed ID: 30580908
    [No Abstract]   [Full Text] [Related]  

  • 15. [Emotion and basal ganglia (II): what can we learn from subthalamic nucleus deep brain stimulation in Parkinson's disease?].
    Péron J; Dondaine T
    Rev Neurol (Paris); 2012; 168(8-9):642-8. PubMed ID: 22901366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brain connectivity changes when comparing effects of subthalamic deep brain stimulation with levodopa treatment in Parkinson's disease.
    Mueller K; Jech R; Růžička F; Holiga Š; Ballarini T; Bezdicek O; Möller HE; Vymazal J; Růžička E; Schroeter ML; Urgošík D
    Neuroimage Clin; 2018; 19():1025-1035. PubMed ID: 30035027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relation of lead trajectory and electrode position to neuropsychological outcomes of subthalamic neurostimulation in Parkinson's disease: results from a randomized trial.
    Witt K; Granert O; Daniels C; Volkmann J; Falk D; van Eimeren T; Deuschl G
    Brain; 2013 Jul; 136(Pt 7):2109-19. PubMed ID: 23801735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expectation and the placebo effect in Parkinson's disease patients with subthalamic nucleus deep brain stimulation.
    Mercado R; Constantoyannis C; Mandat T; Kumar A; Schulzer M; Stoessl AJ; Honey CR
    Mov Disord; 2006 Sep; 21(9):1457-61. PubMed ID: 16721750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Encoding of sequence boundaries in the subthalamic nucleus of patients with Parkinson's disease.
    Herrojo Ruiz M; Rusconi M; Brücke C; Haynes JD; Schönecker T; Kühn AA
    Brain; 2014 Oct; 137(Pt 10):2715-30. PubMed ID: 25031238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beyond nine years of continuous subthalamic nucleus deep brain stimulation in Parkinson's disease.
    Zibetti M; Merola A; Rizzi L; Ricchi V; Angrisano S; Azzaro C; Artusi CA; Arduino N; Marchisio A; Lanotte M; Rizzone M; Lopiano L
    Mov Disord; 2011 Nov; 26(13):2327-34. PubMed ID: 22012750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.